PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
"Implementing a Radioligand Strategy for mCRPC: Your Clinical Questions"
Visit https://www.peervoice.com/ZRS860 to view the entire programme with slides. After completing “"Implementing a Radioligand Strategy for mCRPC: Your Clinical Questions"”, participants will be able to: Apply the data for radioligand therapy in the context of a future therapeutic strategy for metastatic castration-resistant prostate cancer (mCRPC); Identify the patient population that may benefit most from radioligand therapy; Describe the importance of a multidisciplinary team approach to patient care